Update: Recall expanded to Natural Ophthalmics and TRP Company, Inc.
25 murder charges against one physician leads to multiple firings at Ohio hospital.
CVS will expand its health offerings, including nutrition and weight loss.
Both pharmacy groups state that rule should have addressed DIR fees.
Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.
Biosimilar guidance provides “clarity” for drug developers.
The company is donating enough drugs for 200,000 patients for up to 11 years, but does it make up for the high price of the drug?
Premier is exiting the specialty pharmacy market and selling its ProCare Pharmacy company.
Two different versions of tafamadis get the FDA’s nod to treat a rare heart disease.